Chembiochem2022,Vol.23Issue(11) :17.DOI:10.1002/cbic.202100678

Strategies for Interference of Insulin Fibrillogenesis: Challenges and Advances

Sen, Shantanu Ali, Rafat Onkar, Akanksha Ganesh, Subramaniam Verma, Sandeep
Chembiochem2022,Vol.23Issue(11) :17.DOI:10.1002/cbic.202100678

Strategies for Interference of Insulin Fibrillogenesis: Challenges and Advances

Sen, Shantanu 1Ali, Rafat 1Onkar, Akanksha 1Ganesh, Subramaniam 1Verma, Sandeep1
扫码查看

作者信息

  • 1. Indian Inst Technol Kanpur
  • 折叠

Abstract

The discovery of insulin came with very high hopes for diabetic patients. In 2021, the world celebrated the 100th anniversary of the discovery of this vital hormone. However, external use of insulin is highly affected by its aggregating tendency that occurs during its manufacturing, transportation, and improper handling which ultimately leads to its pharmaceutically and biologically ineffective form. In this review, we aim to discuss the various approaches used for decelerating insulin aggregation which results in the enhancement of its overall structural stability and usage. The approaches that are discussed are broadly classified as either a measure through excipient additions or by intrinsic modifications in the insulin native structure.

Key words

aggregation/amyloids/diabetes/inhibitors/insulin/AMYLOID FIBRIL FORMATION/TOTAL CHEMICAL-SYNTHESIS/DISULFIDE BOND/SUBCUTANEOUS INSULIN/GOLD NANOPARTICLES/INJECTION SITES/BOVINE INSULIN/CARBON DOTS/INHIBITION/AGGREGATION

引用本文复制引用

出版年

2022
Chembiochem

Chembiochem

CCR
ISSN:1439-4227
被引量5
参考文献量148
段落导航相关论文